Page 7 - Immunization Action News Today : Breaking News, Live Updates & Top Stories | Vimarsana

'Don't panic' over Johnson & Johnson vaccine pause, experts say. Chances of blood clot is less than 1 in a million. Adrianna Rodriguez, USA TODAY Replay Video UP NEXT Health officials are urging Americans not to panic over news the Food and Drug Administration and the Centers for Disease Control and Prevention issued a recommendation Tuesday for states to pause vaccinations with the Johnson & Johnson COVID-19 vaccine due to blood clots. The agencies said they’re reviewing six reported cases out of nearly 7 million vaccines administered in the U.S., which makes these blood c...

In the meantime, people who got the vaccine within the last three weeks should monitor for symptoms, including a severe headache, abdominal pain, leg pain or shortness of breath, and should seek medical care if these symptoms develop. Health experts say people who have been vaccinated longer than three weeks ago are in the clear. “You’re OK,” Fauci said. “If you look at the time frame when this occurs, it’s pretty tight, from a few days to six to 13 days from the time of vaccination.” He said symptoms from these types of blood clots are pretty noticeable, so Americans shouldn’t...

USA TODAY In just two months, the United States could be swimming in COVID-19 vaccine. The 500 million 0.5 or 0.3-milliliter doses expected to be shipped by then literally are enough to fill a 55,000-gallon swimming pool. As hard as it is to imagine now as people frantically call, click and line up to get vaccinated, the nation is close to shifting from a situation of scarcity to one of abundance. “It's not a switch that flips, but it's a sliding scale that happens differently community by community,” said Andy Slavitt, White House senior adviser for the COVID Response Team. “This is...

After early confusion, protocols for making sure leftover doses of COVID-19 vaccine are used are in place. Experts say shots should not be wasted.

A lack of transparency, a federal-state disconnect and a short supply has complicated America's COVID-19 vaccine rollout.